Ignite Creation Date:
2025-12-25 @ 1:43 AM
Ignite Modification Date:
2026-01-26 @ 4:24 AM
Study NCT ID:
NCT02691494
Status:
COMPLETED
Last Update Posted:
2021-07-13
First Post:
2016-02-22
Is Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Efficacy and Safety of Elagolix in Combination With Estradiol/Norethindrone Acetate for the Management of Heavy Menstrual Bleeding Associated With Uterine Fibroids in Premenopausal Women (Replicate Study)
Sponsor:
AbbVie
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2016-02-03
Start Date Type:
ACTUAL
Primary Completion Date:
2018-02-14
Primary Completion Date Type:
ACTUAL
Completion Date:
2019-01-23
Completion Date Type:
ACTUAL
First Submit Date:
2016-02-22
First Submit QC Date:
None
Study First Post Date:
2016-02-25
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2020-06-12
Results First Submit QC Date:
None
Results First Post Date:
2020-06-30
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
2019-02-11
Disp First Post Date Type:
ACTUAL
Last Update Submit Date:
2021-07-09
Last Update Post Date:
2021-07-13
Last Update Post Date Type:
ACTUAL